Alterations to Plasma Melatonin and Cortisol After Evening Alprazolam Administration in Humans

References

• Johnston E, Ferrier L. Neuroendocrine markers of CNS drug effects. Br J Clin Pharmatol 1980; 10: 5–21
   Google Scholar
• Rees L., Thesis M.D. University of London, London 1970
   Google Scholar
• Barlow S, Knight A, Sullivan F. Plasma corticosterone responses to stress following chronic oral administration of diazepam in the rat. J Pharm Pharmacol 1979; 31: 23–6
   Google Scholar
• Tormey W, Dolphin C, Darragh A. The effects of diazepam on sleep and on the nocturnal release of growth hormone, prolactin, ACTH and cortisol. Br J Clin Pharmacol 1979; 8: 90–2
   Google Scholar
• Havard C, Saldanha V, Bird R, Gardner R. The effect of diazepam on pituitary function in man. J Endocrinol 1972; 52: 79–85
   Google Scholar
• Beary M, Lacey J, Bhat A. The neuroendocrine impact of 3-hydroxy-diazepam (temazepam) in women. Psychopharmacology 1983; 79: 295–7
   Google Scholar
• Mellman T, Uhde T. Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry 1986; 143: 1464–6
   PubMed Web of Science ®Google Scholar
• Patterson J. Alprazolam dependency: use of clonazepam for withdrawal. South Med J 1988; 81: 830–1
   Google Scholar
• Ottenweller J, Tapp W, Natelson B. Effects of chronic alprazolam treatment on plasma concentrations of glucocorticoids, thyroid hormones and testosterone in cardiomyopathic hamsters. Psychopharma-cology 1989; 98: 369–71
   Google Scholar
• Wolkowitz O, Breier A, Doran A, Kelsoe J, Lucas P, Paul S, Pickar D. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: preliminary results. Arch Gen Psychiatry 1988; 45: 664–71
   PubMed Web of Science ®Google Scholar
• Charney D, Breier A, Jatlow P, Heninger G. Behavioural, biochemical and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine. Psychopharmacology 1986; 88: 133–40
   Google Scholar
• Melntyre IM, Burrows G, Norman T. Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol Psychiatry 1988; 24: 105–8
   Google Scholar
• Wetterberg L, Aperia B, Beck-Friis J, . Pineal-hypothalamic-pituitary function in patients with depressive illness. Steroid hormone regulation of the brain, K Fuke, JA Gustafsson, L Wetterberg, et al. Pergamon Press, Oxford 1981; 397–403
   Google Scholar
• Beck-Friis J, Ljunggren J, Thoren M, van Rosen D, Kjellman BF, Wetterberg L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendorinology 1985; 10: 173–86
   PubMed Web of Science ®Google Scholar
• Johnson L. The pineal gland as a modulator of the adrenal and thyroid axes. The pineal gland, vol 3: extra-reproductive effects, RJ Reiter. CRC Press, Boca Raton, Florida 1982; 107–52
   Google Scholar
• Werner S, Brismar K, Wetterberg L, Encroth P. Circadian rhythms of melatonin, prolactin, growth hormone and cortisol in patients with pituitary adenomas, empty sella syndrome and Cushing's syndrome due to adrenal tumors. Advances in the biosciences, vol 29, melatonin: current status and perspectives, N Birau, W Schloot. Pergamon Press, Oxford 1980; 257–61
   Google Scholar
• Wetterberg L, Eriksson O, Friberg V, Vangbo B. A simplified radioimmunoassay for melatonin and its application to biological fluids: preliminary observations on the half-life of plasma melatonin in man. Clin Chim Acta 1980; 86: 169–72
   Google Scholar
• Vaughan G, McDonald S, Jordan R, Allen JP, Bell R, Stevens AE. Melatonin, pituitary function and stress in humans. Psychoneuroendocrinology 1979; 4: 351–62
   PubMed Web of Science ®Google Scholar
• Waldhauser F, Frisch H, Krautgasser-Gasparotti A, Schober E, Beiglmayer C. Serum melatonin is not affected by glucocorticoid replacement in congenital adrenal hyperplasia. Acta Endoerinol 1986; 111: 355–9
   PubMedGoogle Scholar
• Brismar K, Werner S, Wetterberg L. Melatonin and corticosteroid response to metyrapone in patients with pituitary disease. Prog Clin Biol Res 1982; 92: 283–92
   Google Scholar
• Brismar K, Werner S, Thoren M, Wetterberg L. Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion. J Endoerinol Invest 1985; 8: 91–5
   Google Scholar
• Waldhauser F, Lieberman HR, Lynch HJ, et al. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, FSH, TSH, testosterone or cortisol. Neuroendoerinology 1987; 46: 125–30
   PubMed Web of Science ®Google Scholar
• Nickelsen T, Demsisch L, Demisch K, Radermacher B, Schoffling K. Influence of subchronic intakes of melatonin at various times of the day on fatigue and hormonal levels: a placebo-controlled double-blind trial. J Pineal Res 1989; 6: 325–34
   PubMed Web of Science ®Google Scholar
• Melntyre IM, Norman TR, Burrows GD, Armstrong SM. Melatonin. cortisol and prolactin response to acute noeturnal light exposure in healthy volunteers. Psychoneuroendocrinology
   Google Scholar
• Strassman R, Peake G, Qualls C, Lisansky E. Lack of an acute modulatory effect of melatonin on human nocturnal thyrotropin and cortisol secretion. Neuroendocrinology 1988; 48: 387–93
   Google Scholar
• Fraser S, Cowen P, Franklin C, Franey C, Arendt J. Direct radioimmunoassay for melatonin in plasma. Clin Chem 1983; 29: 396–400
   PubMed Web of Science ®Google Scholar
• McLntyre IM, Judd F, Norman T, Burrows GD. Plasma melatonin concentrations in depression. Aust NZ J Psychiatry 1986; 20: 381–3
   PubMed Web of Science ®Google Scholar
• Norman TR, Burrows GD, McIntyre IM. Pharmacokinetic and pharmacodynamic effects of a single nocturnal dose of alprazolam. Int Clin Psychopharmacol 1990; 5: 111–7
   Google Scholar
• Lewy A, Wehr T, Goodwin F, Newsome D, Mackey S. Light suppresses melatonin secretion in humans. Science 1980; 210: 1267–9
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Norman T, Burrows G, Armstrong SM. Human melatonin suppression by light is intensity dependent. J Pineal Res 1989; 6: 149–56
   PubMed Web of Science ®Google Scholar
• Arendt J, Aldhous M, Bojkowski C, English J, Franey C, Poulton A, Skene D. Investigations of pineal function in humans. Advances in pineal research, RJ Reiter, F Fraschini. John Libbey, London 1987; vol II: 223–9
   Google Scholar
• Arendt J, Hampton S, English J, Kwasowski P, Marks V. 24-hour profiles of melatonin, cortisol, insulin, C-peptide and GIP following a meal and subsequent fasting. Clin Endocrinol 1982; 16: 89–95
   PubMed Web of Science ®Google Scholar
• Arato M, Grof E, Grof P, Laszolo I, Brown G. Reproducibility of the overnight melatonin secretion pattern in healthy men. The pineal gland: endocrine aspects, GM Brown, SD Wainwright. Pergamon Press, Oxford 1985; 277–82
   Google Scholar
• Monteleone P, Forziati D, Orazzo C, Maj M. Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J Pineal Res 1989; 6: 253–8
   PubMed Web of Science ®Google Scholar
• Kabuto M, Namua I, Saitoh Y. Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans. Endocrinol Jpn 1986; 33: 405–14
   PubMedGoogle Scholar
• Suranyi-Cadotte B, Lal S, Nair N, Lafaille F. Co-existence of central and peripheral benzodiazepine binding sites in the human pineal gland. Life Sci 1987; 40: 1537–43
   Google Scholar
• Moore R. The retinohypothalamic tract, suprachiasmatic hypothalamic nucleus and central neural mechanisms of circadian rhythm regulation. Biological rhythms and their central mechanism, M Suda, O Hayaishi, H Nakagaiva. Elsevier/North Holland Biomedical Press, Amsterdam 1979; 343–54
   Google Scholar
• Card J, Moore R. The suprachiasmatic nucleus of the golden hamster: immunohistochemical analysis of cell and fibre distribution. Neuroscience 1984; 13: 415–31
   PubMed Web of Science ®Google Scholar
• Terman M, Reme C, Wirz-Justice A. The visual input stage of the mammalian circadian pacemaking system. II: The effect of light and drugs on retinal function. J Biol Rhythms 1991; 6: 31–48
   PubMed Web of Science ®Google Scholar
• Sachar E, Hellman L, Roffwarg P, Halpern F, Fukushima D, Gallagher T. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973; 28: 19–24
   PubMed Web of Science ®Google Scholar
• Turek F, Losee-Olson S. A benzodiazepine used in the treatment of insomnia phase-shifts the mammalian circadian clock. Nature 1986; 321: 167–8
   PubMed Web of Science ®Google Scholar
• Mrosovsky N. Phase response curves for social entrainment. J Comp Physiol 1988; 162: 35–46
   PubMed Web of Science ®Google Scholar
• Van Reeth O, Tecco J, Turek F. Restraint can induce phase dependent delays in the hamster circadian clock. Soc Neurosci Abstr 1987; 15: 492
   Google Scholar
• Mrosovsky N, Salmon P. A behavioural method for accelerating reentrainment of rhythms to new light-dark cycles. Nature 1987; 330: 372–3
   PubMed Web of Science ®Google Scholar
• Rao M, Mager T. Influence of the pineal gland on pituitary function in humans. Psychoneuroendo-crinology 1987; 12: 141–7
   Google Scholar
• Salin-Pascual R, Ortego-Soto H, Huerto-Delgadillo L, Camacho-Arroyo I, Roldan-Roldan Tamarkin G.L. The effect of total sleep deprivation on plasma melatonin and cortisol in healthy human volunteers. Sleep 1988; 11: 362–9
   PubMed Web of Science ®Google Scholar
• Hariharasubramanian N, Nair N, Pilapil C. Circadian rhythm of plasma melatonin and cortisol during the menstrual cycle. The pineal gland—endocrine aspects, GM Brown, SD Wainwright. Pergamon Press, Oxford 1985; 31–6
   Google Scholar